Suchergebnisse - "Child-Pugh classification"

PubPharm (121)

1

Effect of Hepatic Impairment on the Pharmacokinetics of Fenfluramine and Norfenfluramine

enthalten in: Journal of clinical pharmacology | 2024

von Mittur, A. | Madanick, R. | Langlois, M. | +1

2

Evaluation of Pretreatment Albumin-Bilirubin Grade as a Better Prognostic Factor Compared to Child-Pugh Classification in Patients with Hepatocellular Carcinoma Receiving Transarterial Chemoembolization Combined with Radiotherapy

enthalten in: Journal of personalized medicine | 2023

von Lee, J. | Park, J. | Hong, H. | +4

3

Lenvatinib as Second-Line Treatment after Atezolizumab plus Bevacizumab for Unresectable Hepatocellular Carcinoma : Clinical Results Show Importance of Hepatic Reserve Function

enthalten in: Oncology | 2023

von Hiraoka, A. | Kumada, T. | Tada, T. | +42

4

Feasibility of Imaging-Based Quantitative Hepatic Function Assessment : Gd-EOB-DTPA-Enhanced Liver MR Imaging Combined with T1 Mapping

enthalten in: Current medical imaging | 2023

von Dong, Z. | Wang, M. | Feng, Y. | +5

5

Evaluation of Pretreatment Albumin–Bilirubin Grade as a Better Prognostic Factor Compared to Child–Pugh Classification in Patients with Hepatocellular Carcinoma Receiving Transarterial Chemoembolization Combined with Radiotherapy

in: Journal of Personalized Medicine | 2023

von Jason Joon Bock Lee | Jun Su Park | Hyun Pyo Hong | +4

6

Clinical analysis of insulin resistance in liver cirrhosis patients

in: Shanghai Jiaotong Daxue xuebao. Yixue ban | 2023

von SHI Cuicui | ZHANG Jie | HUANG Heming | +2

7

Prognosis and treatment pattern of advanced hepatocellular carcinoma after failure of first-line atezolizumab and bevacizumab treatment

enthalten in: Hepatology international | 2022

von Chen, C. | Feng, Y. | Yen, C. | +6

8

Effectiveness of Lenvatinib Versus Sorafenib for Unresectable Hepatocellular Carcinoma in Patients with Hepatic Decompensation

enthalten in: Digestive diseases and sciences | 2022

von Park, M. | Lee, Y. | Moon, H. | +9

9

Prognosis and treatment pattern of advanced hepatocellular carcinoma after failure of first-line atezolizumab and bevacizumab treatment

enthalten in: Hepatology international | 2022

von Chen, C. | Feng, Y. | Yen, C. | +6

10

Prognosis and treatment pattern of advanced hepatocellular carcinoma after failure of first-line atezolizumab and bevacizumab treatment

enthalten in: Hepatology international | 2022

von Chen, C. | Feng, Y. | Yen, C. | +6

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[13]